Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-08

Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the valsartan/amlodipine combination in patients with severe hypertension demonstrated efficacy in lowering blood pressure and a safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED